BioAmber Inc. 4
4 · BioAmber Inc. · Filed Feb 13, 2017
Insider Transaction Report
Form 4
BioAmber Inc.BIOA
Millis James
Chief Technology Officer
Transactions
- Award
Stock-Option (right to buy)
2017-02-09+60,686→ 60,686 totalExercise: $3.55Exp: 2022-02-08→ Common Shares (60,686 underlying) - Award
Stock-Option (right to buy)
2017-02-09+50,000→ 50,000 totalExercise: $3.55Exp: 2027-02-08→ Common Shares (50,000 underlying)
Footnotes (2)
- [F1]vesting monthly over one (1) year from the grant date
- [F2]Vesting as follows: twenty-five percent (25%) vesting at the first anniversary date following the grant date, and the remaining seventy-five percent (75%) vesting on a monthly basis over the three (3) following years.